| Accession Number: | 0001136261-22-000159 |
| Date: | 2022-03-31 |
| Issuer: | SEELOS THERAPEUTICS, INC. (SEEL) |
| Original Submission Date: |
MEHRA RAJ
C/O SEELOS THERAPEUTICS, INC.
300 PARK AVENUE, 2ND FLOOR
NEW YORK, NY 10022
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2022-03-31 | P | 66,667 | a | $0.85 | 3,281,546 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | the price reported in column 4 is a weighted average purchase price. these shares were acquired in multiple open market transactions at prices ranging from $0.8454 per share to $0.8600 per share, inclusive. the reporting person undertakes to provide to the staff of the securities and exchange commission, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares acquired at each separate price. |
